Bio-Rad Laboratories
(BIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | 1,778,316 | 1,765,667 | 1,467,626 | 1,247,779 | 1,166,711 |
| Accounts payable and accrued liabilities | -1,386,382 | -1,495,669 | -1,225,968 | -1,058,977 | -1,003,264 |
| Other Working Capital | 315,714 | 196,421 | 194,572 | 119,614 | 108,284 |
| Other Operating Activity | -382,574 | -275,048 | -244,650 | -190,187 | -163,447 |
| Operating Cash Flow | $325,074 | $191,371 | $191,580 | $118,229 | $108,284 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -61,081 | 1,106 | 200,026 | -155,404 | 68,968 |
| PPE Investments | -66,795 | -84,809 | -60,595 | -52,987 | -36,055 |
| Net Acquisitions | -35,990 | -53,014 | -387,673 | -33,299 | -4,344 |
| Purchase Sale Intangibles | -9,566 | -4,000 | -2,075 | N/A | -5,000 |
| Other Investing Activity | -12,086 | -9,390 | -6,187 | 33,942 | -34,741 |
| Investing Cash Flow | $-175,952 | $-146,107 | $-254,429 | $-207,748 | $-6,172 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 294,750 | 1,600 | 24 | N/A | N/A |
| Debt Repayment | -6,823 | -11,589 | -17,720 | -487 | -447 |
| Common Stock Issued | 10,286 | 12,912 | 11,580 | 9,923 | 8,915 |
| Other Financing Activity | -4,280 | 3,408 | -1,334 | 726 | -7,178 |
| Financing Cash Flow | $293,933 | $6,331 | $-7,450 | $10,162 | $1,290 |
| Exchange Rate Effect | 2,359 | -8,835 | 8,456 | 6,248 | -2,420 |
| Beginning Cash Position | 204,524 | 161,764 | 223,607 | 296,716 | 195,734 |
| End Cash Position | 649,938 | 204,524 | 161,764 | 223,607 | 296,716 |
| Net Cash Flow | $445,414 | $42,760 | $-61,843 | $-73,109 | $100,982 |
| Free Cash Flow | |||||
| Operating Cash Flow | 325,074 | 191,371 | 191,580 | 118,229 | 108,284 |
| Capital Expenditure | -68,044 | -84,809 | -60,595 | -52,987 | -36,055 |
| Free Cash Flow | 257,030 | 106,562 | 130,985 | 65,242 | 72,229 |